Reasons for Nonadherence to Statins – A Systematic Review of Reviews

References

• World Health Organization. Global Status Report on Noncommunicable Diseases 2010 2011. ISBN 978 92 4 156422 9.
   Google Scholar
• Mihaylova B, Emberson J, Blackwell L, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380(9841):581–590. doi:10.1016/S0140-6736(12)60367-5
   PubMed Web of Science ®Google Scholar
• Guilbert JJ. The World Health Report 2002 - Reducing Risks, Promoting Healthy Life. World Health Organization. Vol. 16. 2003. doi:10.1080/1357628031000116808
   Google Scholar
• Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease (Review). Cochrane Database Syst Rev. 2013;1:1–97. doi:10.1002/14651858.CD004816.pub5.www.cochranelibrary.com
   Google Scholar
• Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344(8934):1383–1389. doi:10.1016/S0140-6736(94)90566-5
   PubMed Web of Science ®Google Scholar
• Lemstra M, Blackburn D. Nonadherence to statin therapy: discontinuation after a single fill. Can J Cardiol. 2012;28(5):567–573. doi:10.1016/j.cjca.2012.03.018
   PubMed Web of Science ®Google Scholar
• Chaudhry HJ, McDermott B. Recognizing and improving patient nonadherence to statin therapy. Curr Atheroscler Rep. 2008;10(1):19–24. doi:10.1007/s11883-008-0004-4
   PubMed Web of Science ®Google Scholar
• Helin-salmivaara A, Lavikainen P, Korhonen M, et al. Patterns of statin use among 10 cohorts of new users from 1995 to 2004: a register-based nationwide study. Am J Manag Care. 2010;16(2):116–122.
   PubMed Web of Science ®Google Scholar
• Casula M, Tragni E, Catapano AL. Adherence to lipid-lowering treatment: the patient perspective. PatientPreferAdherence. 2012;6(1177–889X(Electronic)):805–814. doi:10.2147/PPA.S29092
   Google Scholar
• Perreault S, Blais L, Dragomir A, et al. Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease. Eur J Clin Pharmacol. 2005;61(9):667–674. doi:10.1007/s00228-005-0980-z
   Web of Science ®Google Scholar
• Ofori-Asenso R, Zomer E, Curtis A, et al. Patterns and predictors of adherence to statin therapy among older patients: protocol for a systematic review. JMIR Res Protoc. 2017;6(3):e39. doi:10.2196/resprot.7195
   Web of Science ®Google Scholar
• Smith V, Devane D, Begley CM, Clarke M. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol. 2011;11(1). doi:10.1186/1471-2288-11-15
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339(7716):332–336. doi:10.1136/bmj.b2535
   Web of Science ®Google Scholar
• Miller SA, Forrest JL. Enhancing your practice through evidence-based decision making: PICO, learning how to ask good questions. J Evid Based Dent Pract. 2001;1(2):136–141. doi:10.1067/med.2001.118720
   Google Scholar
• Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:4008. doi:10.1136/bmj.j4008
   PubMed Web of Science ®Google Scholar
• Thomas J, Brunton J, Graziosi S. EPPI-Reviewer 4.0: Software for Research Synthesis. London: Social Science Research Unit, Institute of Education, University of London; 2010.
   Google Scholar
• Hope HF, Binkley GM, Fenton S, Kitas GD, Verstappen SMM, Symmons DPM. Systematic Review of the Predictors of Statin Adherence for the Primary Prevention of Cardiovascular Disease. PLoS One. 2019;14(1):1-38. doi:10.1371/journal.pone.0205138
   Google Scholar
• Lewey J, Shrank WH, Bowry ADK, Kilabuk E, Brennan TA, Choudhry NK. Gender and racial disparities in adherence to statin therapy: a meta-analysis. Am Heart J. 2013;165(5):665–678.e1. doi:10.1016/j.ahj.2013.02.011
   PubMed Web of Science ®Google Scholar
• Ofori-Asenso R, Jakhu A, Curtis AJ, et al. A systematic review and meta-analysis of the factors associated with nonadherence and discontinuation of statins among people aged ≥65 years. Journals Gerontol Ser A. 2018:1–8. doi:10.1093/gerona/glx256
   Web of Science ®Google Scholar
• Mann DM, Woodward M, Munther P, Falzon L, Kronish I. Predictors of non-adherence to statins: a systematic review and meta-analysis. Ann Pharmacother. 2010;44(9):1410–1421. doi:10.1345/aph.1P150
   PubMed Web of Science ®Google Scholar
• Chee Y, Chan V, Tan N. Understanding patients’ perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review. Singapore Med J. 2014;55(8):416–421. doi:10.11622/smedj.2014099
   PubMed Web of Science ®Google Scholar
• Lemstra M, Blackburn D, Crawley A, Fung R. Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis. Can J Cardiol. 2012;28(5):574–580. doi:10.1016/j.cjca.2012.05.007
   PubMed Web of Science ®Google Scholar
• Mann BS, Barnieh L, Tang K, et al. Association between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: a systematic review. PLoS One. 2014;9(3):e89168. doi:10.1371/journal.pone.0089168
   PubMed Web of Science ®Google Scholar
• Banerjee A, Khandelwal S, Nambiar L, et al. Health system barriers and facilitators to medication adherence for the secondary prevention of cardiovascular disease: a systematic review. Open Hear. 2016;3(2):e000438. doi:10.1136/openhrt-2016-000438
   Google Scholar
• Ju A, Hanson CS, Banks E, Korda R, Craig JC, Usherwood T. Patient beliefs and attitudes to taking statins: systematic review of qualitative studies. Br J Gen Pract. 2018;68(671):e408–e419. doi:10.3399/bjgp18X696365
   PubMed Web of Science ®Google Scholar